Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ArrePath Logo
ArrePath Growth Score
48
CB Rank
36368
Heat Score
12
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Founded
obfuscation
PrivateSeed Princeton, New Jersey, United States11-50 arrepath.com/
Biotechnology
Health Care
Medical
Overview

ArrePath
Total Funding
obfuscation
Growth Score
48
Heat Score
12

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score48
-13 pts
in past quarter
Heat Score 12
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ArrePath

CB Rank
36368
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Founded
obfuscation
PrivateSeed Princeton, New Jersey, United States11-50 arrepath.com/
Biotechnology
Health Care
Medical

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name ARREPATH, INC.
Operating Status Active
Company Type For Profit
About the Company
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Phone Number +1 609.423.1571
Predictions & Insights

Growth Insight

See this Growth Insight
ArrePath is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

AI/ML Drug Discovery Platform
A platform that uses artificial intelligence and machine learning to identify novel small molecule therapeutics by optimizing multiple drug properties simultaneously.
AP-001 Program
A lead antibiotic program targeting outpatient urinary tract infections and hospital avoidance through novel antibacterial compounds.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed
obfuscation
Seed Round - ArrePath Logo
Seed Round - ArrePath
5
obfuscation
Boehringer Ingelheim Venture FundSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 5

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 23, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 23, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

213
334.69%
 in past month

IT Spend

$327.2KThis year, ArrePath is projected to spend $327.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Snowpark Logo
Snowpark
81
Nvidia Corporation Logo
Nvidia Corporation
77
App Analytics Companies Logo
App Analytics Companies
76

Active Website Tech Count

10ArrePath is actively using 10 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Common Crawl.

Total IP

5The intellectual property of ArrePath includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ArrePath's headquarters? ArrePath is located in Princeton, New Jersey, United States.Who invested in ArrePath? ArrePath has 8 investors including Innospark Ventures and  Boehringer Ingelheim Venture Fund.When was the last funding round for ArrePath? ArrePath closed its last funding round on
obfuscation
from a Seed round.Who are ArrePath's competitors? Alternatives and possible competitors to ArrePath may include Debiopharm Group, Spero Therapeutics, and  CARB-X.How much funding has ArrePath raised to date? ArrePath has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|